PHR — Pharmena SA Share News
0.000.00%
Last trade - 00:00- PLN33.30m
- PLN27.69m
- PLN1.58m
Brief: Pharmena Signs Two Distribution Deals For US, Canada And Mexico Markets
Brief: Pharmena 9-Month Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Plans To Separate Dermocosmetic Business
Brief: Pharmena H1 Net Loss Narrows To 0.6 Mln Zlotys
Brief: Pharmena Q1 Net Loss Narrows To 0.2 Mln Zlotys
Brief: Jerzy Gebicki Lowers His Stake In Pharmena To 1.65% From 6.14%
Brief: Pharmena FY 2021 Net Loss Narrows To 4.6 Mln Zlotys
Brief: Pharmena Gets Mexican Patent For 1-MNA In Cardiac Cases
Brief: Pharmena 9-Month Net Loss Narrows To 3.1 Mln Zlotys
Brief: Pharmena H1 Net Loss Narrows To 2.5 Mln Zlotys
Brief: Pharmena To Extend Strategy By Product Addressed At Covid-19 Patients With Complications
Brief: Pharmena Q1 Net Loss Narrows To 0.6 Mln Zlotys
Brief: Pharmena FY Net Loss Narrows To 6.9 Mln Zlotys
Brief: Pharmena Signs Deal With Polish Development Fund For Up To 4.6 Mln Zloty Liquidity Loan
Brief: Pharmena Starts Second Pre-Clinical Trial To Determine Effective Dose Of 1-MNA Drug In SARS-CoV-2 Infection
Brief: Pharmena Q3 Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Starts Pre-Clinical Trial To Determine Maximum Tolerable Dose Of 1-MNA In Sars-Cov-2 Infection
Brief: Pharmena Signs Deal For Cooperation On Pre-Clinical Tests Of 1-MMNA Candidate For Covid-19 Drug
Brief: Pharmena Eyes 1.5 Mln Zlotys In Share Issue To Test 1-MNA In COVID-19 Treatment